Microglia As conTroller of braIn metaboLism During Aging

ERC (European Research Council)HORIZON-ERCID: 101055323
EC Contribution
€25,000
Consortium Size
1 orgs
Start Year
2023
Summary

Microglia represent the main brain residential immune cells. In the last years evidence emerged that, besides representing the first line of defense against pathogenic insults, microglia are also centrally involved in physiological functions essential for correct CNS development and function. Microglia, in a spatially and temporally controlled manner, influence neuronal apoptosis, neurogenesis and myelin formation and manage synapse homeostasis, including removing supernumerary synapses during development. These widely heterogeneous roles are supported by distinct subtypes -or states- of microglia, present in different regions of the brain and at different times during CNS development. In the last years, Triggering Receptor Expressed on Myeloid cells 2 (Trem2) emerged as a key gene which controls the microglial metabolic state, in addition to directing synapse elimination and shaping the functional brain connectivity. In the present project, I propose that microglia, via Trem2, direct the genetic signature of specific subgroups of brain cells, shifting them toward specific metabolic and developmental patterns. I hypothesize that this mechanism is key for the control of metabolism in the hypothalamus, where the neuronal contingents orchestrating systemic energy homeostasis reside. By using a combination of transcriptomics, multiplex protein expression analysis and cell-based imaging methods, I will determine which subsets of microglia cooperate within hypothalamic centers and will define the underlying mechanisms. I will also assess whether defects in this orchestrated crosstalk affect the central regulation of energy and glucose homeostasis during aging. Data from this study will provide comprehensive knowledge of microglia functions in shaping hypothalamic complexity and endocrine output. Also, they will offer a targeting potential for new therapeutic strategies that could reverse immunometabolic dysfunction by modulation of hypothalamic microglial function.

Consortium (1)

Project Results (7)

Source: CORDIS, the EU research results database.

Publications (6)
Neurodevelopmental origins of structural and psychomotor defects in CXCR4-linked primary immunodeficiency
Neuron· 2025DOI
Giulia Demenego; Sara Mancinelli; Antonella Borreca; Rosalba Olga Proce; Vanessa Aragona; Matteo Miotto; Marco Cremonesi; Laura Zucchelli; Irene Corradini; Eugene Kim; Katarina Ilic; Edoardo Fraviga; Luca Pellegrino; Raffaele Badolato; Roberto Rusconi; Davide Pozzi; Marinos Kallikourdis; Diana Cash; Michela Matteoli; Simona Lodato
Brain, Behavior, and Immunity
Brain, Behavior, and Immunity· 2024DOI
Borreca, Antonella; Mantovani, Cristina; Desiato, Genni; Corradini, Irene; Filipello, Fabia; Elia, Chiara Adriana; D'Autilia, Francesca; Santamaria, Giulia; Garlanda, Cecilia; Morini, Raffaella; Pozzi, Davide; Matteoli, Michela
Glia
Glia· 2024DOI
Michela Matteoli
Immunity
Immunity· 2024DOI
Tagliatti, Erica; Desiato, Genni; Mancinelli, Sara; Bizzotto, Matteo; Gagliani, Maria C; Faggiani, Elisa; Hernández-Soto, Rebeca; Cugurra, Andrea; Poliseno, Paola; Miotto, Matteo; Argüello, Rafael J; Filipello, Fabia; Cortese, Katia; Morini, Raffaella; Lodato, Simona; Matteoli, Michela
Prenatal drivers of microglia vulnerability in the adult
Immunological Reviews· 2024DOI
Erica Tagliatti, Matteo Bizzotto, Raffaella Morini, Fabia Filipello, Marco Rasile, Michela Matteoli
Immune synaptopathies: how maternal immune activation impacts synaptic function during development
The EMBO Journal· 2023DOI
Michela Matteoli; Davide Pozzi; Matteo Fossati; Elisabetta Menna
Other Results (1)
Periodic Reporting for period 1 - MATILDA (Microglia As conTroller of braIn metaboLism During Aging)